Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy.
Academic Article
Overview
publication date
- February 1, 2016
published in
- Annals of translational medicine Journal
Identity
PubMed Central ID
- PMC4779772
Scopus Document Identifier
- 85006207160
Digital Object Identifier (DOI)
- 10.3978/j.issn.2305-5839.2015.10.40
PubMed ID
- 27004213
Additional Document Info
has global citation frequency
volume
- 4
issue
- 4